Literature DB >> 10470455

History and international developments in cancer staging.

M Gospodarowicz1, L Benedet, R V Hutter, I Fleming, D E Henson, L H Sobin.   

Abstract

OBJECTIVE: To inform the reader of the objectives of staging classification, and review history of the development of modern staging classifications in cancer.
DESIGN: Review of the literature documenting the development of modern cancer staging systems with the emphasis on the history of the development of the TNM classification by the UICC and the history of the Canadian Committee on Cancer Staging. The underlying principles of the TNM system have been reviewed in the context of modern cancer practice.
CONCLUSION: In the era of the multidisciplinary approach to cancer management, staging allows precision in documenting disease extent, thereby enhancing the quality of patient care. The recording of cancer stage at diagnosis is necessary to optimise patient care and provides a valuable means for recording patterns of disease presentation and monitoring advances in diagnosis and therapy. The objectives of staging described in the TNM staging system are as valid today as when implemented almost 50 years ago.

Entities:  

Mesh:

Year:  1998        PMID: 10470455

Source DB:  PubMed          Journal:  Cancer Prev Control        ISSN: 1206-548X


  18 in total

1.  In brief: classifications in brief: enneking classification: benign and malignant tumors of the musculoskeletal system.

Authors:  Muhammad Umar Jawad; Sean P Scully
Journal:  Clin Orthop Relat Res       Date:  2010-07       Impact factor: 4.176

Review 2.  Nomograms in oncology: more than meets the eye.

Authors:  Vinod P Balachandran; Mithat Gonen; J Joshua Smith; Ronald P DeMatteo
Journal:  Lancet Oncol       Date:  2015-04       Impact factor: 41.316

3.  American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine.

Authors:  Michael W Kattan; Kenneth R Hess; Mahul B Amin; Ying Lu; Karl G M Moons; Jeffrey E Gershenwald; Phyllis A Gimotty; Justin H Guinney; Susan Halabi; Alexander J Lazar; Alyson L Mahar; Tushar Patel; Daniel J Sargent; Martin R Weiser; Carolyn Compton
Journal:  CA Cancer J Clin       Date:  2016-01-19       Impact factor: 508.702

Review 4.  2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference.

Authors:  Mitchell M Levy; Mitchell P Fink; John C Marshall; Edward Abraham; Derek Angus; Deborah Cook; Jonathan Cohen; Steven M Opal; Jean-Louis Vincent; Graham Ramsay
Journal:  Intensive Care Med       Date:  2003-03-28       Impact factor: 17.440

5.  The TNM classification of malignant tumours-towards common understanding and reasonable expectations.

Authors:  Brian O'Sullivan; James Brierley; David Byrd; Fred Bosman; Sean Kehoe; Carol Kossary; Marion Piñeros; Elizabeth Van Eycken; Hannah K Weir; Mary Gospodarowicz
Journal:  Lancet Oncol       Date:  2017-07       Impact factor: 41.316

6.  Which Is the Optimal Extent of Resection in Middle Third Gastric Cancer between Total Gastrectomy and Subtotal Gastrectomy?

Authors:  Ji Hyun Lee; Yong Il Kim
Journal:  J Gastric Cancer       Date:  2010-12-31       Impact factor: 3.720

7.  Neighborhood socio-economic disadvantage and race/ethnicity as predictors of breast cancer stage at diagnosis.

Authors:  Yvonne N Flores; Pamela L Davidson; Terry T Nakazono; Daisy C Carreon; Cynthia M Mojica; Roshan Bastani
Journal:  BMC Public Health       Date:  2013-11-11       Impact factor: 3.295

8.  Categorizing the characteristics of human carcinogens: a need for specificity.

Authors:  Carr J Smith; Thomas A Perfetti; A Wallace Hayes; Sir Colin Berry; James E Trosko; Judy A King; Jay I Goodman; C Glenn Begley; Anthony Dayan
Journal:  Arch Toxicol       Date:  2021-06-20       Impact factor: 5.153

9.  Collection of population-based cancer staging information in Western Australia--a feasibility study.

Authors:  Timothy Threlfall; Jana Wittorff; Padabphet Boutdara; Jane Heyworth; Paul Katris; Harry Sheiner; Lin Fritschi
Journal:  Popul Health Metr       Date:  2005-08-17

Review 10.  The PIRO (predisposition, insult, response, organ dysfunction) model: toward a staging system for acute illness.

Authors:  John C Marshall
Journal:  Virulence       Date:  2013-11-01       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.